Cogent Biosciences, Inc. - COGT

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 21
Latest filed: Aug 13, 2026
Form Count
4 10
SCHEDULE 13G/A 4
8-K 4
SCHEDULE 13G 1
SCHEDULE 13D/A 1
144 1

Latest files

Filed Form Report period Accession SEC
Aug 13, 2026 SCHEDULE 13G/A 0001193805-26-001082 View
Aug 10, 2026 8-K Aug 10, 2026 0001193125-26-342695 View
Aug 10, 2026 8-K Aug 10, 2026 0001193125-26-341315 View
Jul 31, 2026 SCHEDULE 13G 0002100119-26-001323 View
Jul 27, 2026 SCHEDULE 13G/A 0002012383-26-002235 View
Jul 06, 2026 4 Jul 01, 2026 0001193125-26-296249 View
Jun 11, 2026 8-K Jun 09, 2026 0001193125-26-267566 View
Jun 11, 2026 4 Jun 09, 2026 0001193125-26-267666 View
Jun 11, 2026 4 Jun 09, 2026 0001193125-26-267667 View
Jun 11, 2026 4 Jun 09, 2026 0001193125-26-267670 View
Jun 11, 2026 4 Jun 09, 2026 0001193125-26-267662 View
Jun 11, 2026 4 Jun 09, 2026 0001193125-26-267663 View
Jun 11, 2026 4 Jun 09, 2026 0001193125-26-267665 View
May 21, 2026 4 May 19, 2026 0001193125-26-234578 View
May 14, 2026 SCHEDULE 13G/A 0001193805-26-000609 View
May 05, 2026 8-K May 05, 2026 0001193125-26-205124 View
Apr 03, 2026 4 Apr 01, 2026 0001193125-26-142082 View
Mar 31, 2026 SCHEDULE 13D/A 0001104659-26-038056 View
Mar 31, 2026 4 Mar 31, 2026 0001104659-26-038057 View
Mar 31, 2026 144 0001104659-26-038058 View
Mar 26, 2026 SCHEDULE 13G/A 0000102909-26-000905 View